Maricel Subirá

883 total citations
24 papers, 624 citations indexed

About

Maricel Subirá is a scholar working on Oncology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Maricel Subirá has authored 24 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Maricel Subirá's work include Neutropenia and Cancer Infections (10 papers), Antifungal resistance and susceptibility (8 papers) and Fungal Infections and Studies (8 papers). Maricel Subirá is often cited by papers focused on Neutropenia and Cancer Infections (10 papers), Antifungal resistance and susceptibility (8 papers) and Fungal Infections and Studies (8 papers). Maricel Subirá collaborates with scholars based in Spain and Colombia. Maricel Subirá's co-authors include Rodrigo Martino, Jorge Sierra, Salut Brunet, Rafael de la Cámara, Montserrat Rovira, Lourdes Vázquez, Anna Sureda, Albert Altés, Guillermo Sanz and Carlos Solano and has published in prestigious journals such as Blood, Journal of Antimicrobial Chemotherapy and British Journal of Haematology.

In The Last Decade

Maricel Subirá

24 papers receiving 612 citations

Peers

Maricel Subirá
Nancy Bunin United States
J. Maertens Belgium
M Buelli Italy
Alejandro Restrepo United States
Iris D. Gersten United States
Maricel Subirá
Citations per year, relative to Maricel Subirá Maricel Subirá (= 1×) peers Pascale Frère

Countries citing papers authored by Maricel Subirá

Since Specialization
Citations

This map shows the geographic impact of Maricel Subirá's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maricel Subirá with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maricel Subirá more than expected).

Fields of papers citing papers by Maricel Subirá

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maricel Subirá. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maricel Subirá. The network helps show where Maricel Subirá may publish in the future.

Co-authorship network of co-authors of Maricel Subirá

This figure shows the co-authorship network connecting the top 25 collaborators of Maricel Subirá. A scholar is included among the top collaborators of Maricel Subirá based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maricel Subirá. Maricel Subirá is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vives, Susana, Albert Oriol, Salut Brunet, et al.. (2015). Feasibility and efficacy of outpatient therapy with intermediate dose cytarabine, fludarabine and idarubicin for patients with acute myeloid leukaemia aged 70 or older. European Journal Of Haematology. 95(6). 576–582. 5 indexed citations
3.
Martino, Rodrigo, Montserrat Cortés, Maricel Subirá, et al.. (2005). Efficacy and toxicity of intermediate-dose amphotericin B lipid complex as a primary or salvage treatment of fungal infections in patients with hematological malignancies. Leukemia & lymphoma. 46(10). 1429–1435. 15 indexed citations
4.
Subirá, Maricel, Rodrigo Martino, Lucía Gómez, et al.. (2004). Low‐dose amphotericin b lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies – a randomized, controlled trial. European Journal Of Haematology. 72(5). 342–347. 61 indexed citations
5.
Subirá, Maricel, Anna Sureda, Rodrigo Martino, et al.. (2003). Allogeneic stem cell transplantation with reduced-intensity conditioning is potentially feasible as an outpatient procedure. Bone Marrow Transplantation. 32(9). 869–872. 17 indexed citations
7.
Subirá, Maricel, Rodrigo Martino, Montserrat Rovira, et al.. (2003). Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Annals of Hematology. 82(2). 80–82. 70 indexed citations
9.
Martino, Rodrigo, Maricel Subirá, Montserrat Rovira, et al.. (2002). Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients. British Journal of Haematology. 116(2). 475–482. 171 indexed citations
10.
Subirá, Maricel, Rodrigo Martino, Anna Sureda, et al.. (2001). Safety and efficacy of low-dose amphotericin B lipid complex forempirical antifungal therapy of neutropenic fever in patients withhematologic malignancies. Methods and Findings in Experimental and Clinical Pharmacology. 23(9). 505–505. 5 indexed citations
11.
Subirá, Maricel, Anna Sureda, Rodrigo Martino, et al.. (2000). Autologous stem cell transplantation for high-risk Hodgkin's disease: improvement over time and impact of conditioning regimen.. PubMed. 85(2). 167–72. 8 indexed citations
12.
Martino, Rodrigo, Maricel Subirá, Mar Bellido, et al.. (1999). Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation. Bone Marrow Transplantation. 24(3). 283–287. 44 indexed citations
13.
Martino, Rodrigo, Maricel Subirá, A Domingo-Albós, et al.. (1999). Low-Dose Amphotericin B Lipid Complex for the Treatment of Persistent Fever of Unknown Origin in Patients with Hematologic Malignancies and Prolonged Neutropenia. Chemotherapy. 45(3). 205–212. 7 indexed citations
14.
15.
Martino, Rodrigo, Maricel Subirá, Anna Sureda, & Jorge Sierra. (1999). Amphotericin B lipid complex at 3 mg/kg/day for treatment of invasive fungal infections in adults with haematological malignancies. Journal of Antimicrobial Chemotherapy. 44(4). 569–572. 11 indexed citations
16.
Wägner, Ana M., et al.. (1999). Chlorambucil-induced inappropriate antidiuresis in a man with chronic lymphocytic leukemia. Annals of Hematology. 78(1). 37–38. 3 indexed citations
17.
Martino, Rodrigo, Maricel Subirá, Albert Altés, et al.. (1998). Effect of Discontinuing Prophylaxis with Norfloxacin in Patients with Hematologic Malignancies and Severe Neutropenia. Acta Haematologica. 99(4). 206–211. 28 indexed citations
18.
Subirá, Maricel, et al.. (1998). Bone marrow involvement in lymphoblastic lymphoma and small non-cleaved cell lymphoma: the role of trephine biopsy.. PubMed. 82(5). 594–5. 3 indexed citations
19.
Vanaclocha, Vicente, José María Viéitez, Javier Aristu, et al.. (1996). High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients.. PubMed. 18(1). 143–9. 25 indexed citations
20.
Sureda, Anna, Salut Brunet, B Amill, et al.. (1995). Peripheral blood stem cell mobilization following salvage chemotherapy (IAPVP-16) plus granulocyte colony-stimulating factor and autografting for non-Hodgkin's lymphoma.. PubMed. 27(4). 2355–6. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026